Ovid Therapeutics
OVID
#7730
Rank
C$0.59 B
Marketcap
C$3.15
Share price
-5.98%
Change (1 day)
59.80%
Change (1 year)

EPS for Ovid Therapeutics (OVID)

EPS in 2026 (TTM): C-$0.44

According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$0.44. In 2025 the company made an earnings per share (EPS) of C-$0.44 an increase over its 2024 EPS that were of C-$0.54.

EPS history for Ovid Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.44-2.14%
2025C-$0.44-18.42%
2024C-$0.54
2022C-$1.10-143.5%
2021C$2.54-226.43%
2020C-$2.01-11.39%
2019C-$2.27-25.47%
2018C-$3.04-24.06%
2017C-$4.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94 335.48%๐Ÿ‡บ๐Ÿ‡ธ USA